Ciencias de la Salud
Área
José María
Miró Meda
Publicacións nas que colabora con José María Miró Meda (51)
2020
-
A Contemporary Picture of Enterococcal Endocarditis
Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494
2019
-
HTLV testing of solid organ transplant donors
Clinical Transplantation
-
HTLV-1 infection in solid organ transplant donors and recipients in Spain
BMC Infectious Diseases, Vol. 19, Núm. 1
-
Role of age and comorbidities in mortality of patients with infective endocarditis
European Journal of Internal Medicine, Vol. 64, pp. 63-71
2017
-
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2869-2878
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
2016
-
Infection-related and -unrelated malignancies, HIV and the aging population
HIV Medicine, Vol. 17, Núm. 8, pp. 590-600
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
2015
-
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
HIV Medicine, Vol. 16, Núm. 9, pp. 533-543
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
Infection, Vol. 42, Núm. 4, pp. 757-762
-
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study
BMC Nephrology, Vol. 15, Núm. 1
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
-
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe
PLoS ONE, Vol. 9, Núm. 1
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12